Estimation of podocyte dysfunction by nephrinuria severity in proteinuric forms of chronic glomerulonephritis

Cite item

Full Text


Aim. To evaluate severity of nephrinuria (NU) as a marker of podocyte dysfunction (PD) in patients with proteinuric forms of chronic glomerulonephritis (CGN) and to specify efficacy of this test for assessment of activity and prognosis of CGN.
Material and methods. We examined 74 CGN patients: 18 with inactive nephritis (group 1), 18 - with subnephrotic proteinuria (group 2), 38 - with nephrotic syndrome - NS (group 3). The control group consisted of 10 healthy subjects. Urinary excretion of nephrin was studied with indirect enzyme immunoassay. A response to immunosuppressive treatment (IST) was studied in 23 NS patients depending on a baseline NU level.
Results. An NU level was higher in patients with proteinuric forms of CGN (groups 2 and 3) than in inactive disease and in healthy subjects, in NS patients significantly higher than in less severe proteinuria. NU was significantly higher in arterial hypertension, in persistent NS. Remission of NS was achieved within 6 months of treatment in 9 of 11 (82%) patients with a baseline NU level < 17 ng/ml. Eight from 12 (67%) patients with high NU did not respond to IST conducted for 9 months to 2 years. ROC-curve construction showed that NU assessment in NS patients has high informative value in assessment of prognosis and efficacy of treatment in 6 months to come.
Conclusion. The NU test in CGN patients is an informative diagnostic test allowing prognosis of a response to IST and assessment of PD severity.

About the authors

Natal'ya Viktorovna Chebotareva


Irina Nikolaevna Bobkova


Lidiya Vladimirovna Kozlovskaya

Zalina Georgievna Tsopanova


N V Chebotareva

I.M. SechenovFirst Moscow State Medical University

I.M. SechenovFirst Moscow State Medical University

I N Bobkova

I.M. SechenovFirst Moscow State Medical University

I.M. SechenovFirst Moscow State Medical University

L V Kozlovskaya

I.M. SechenovFirst Moscow State Medical University

I.M. SechenovFirst Moscow State Medical University

Z G Tsopanova

I.M. SechenovFirst Moscow State Medical University

I.M. SechenovFirst Moscow State Medical University


  1. Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration: Nephrin a key component of the slit diaphragm. J. Am. Soc. Nephrol. 1999; 10: 2440-2445.
  2. Shankland S. J. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006; 69: 2131- 2147.
  3. Kriz W., Elger M., Nagata M. et al. The role of podocytes in the development of glomerular sclerosis. Kidney Int. 1994; 45: S64-S72.
  4. Wiggins J. E., Goyal M., Sanden K. et al. Podocyte hypertrophy, "adaptation" and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the ageing rat: prevention by calorie restriction. J. Am. Soc. Nephrol. 2005; 16: 2953-2966.
  5. Luimula P., Aaltonen P., Ahola H. et al. Alternatively spliced nephrin experimental glomerular disease of the rat. Pediatr. Res. 2000; 48 (6): 759-762.
  6. Patari A., Forsblom C., Havana M. et al. Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 2003; 52: 2969-2974.
  7. Topham P. S., Haydar S. A., Kuphal R. et al. Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesion. Kidney Int. 1999; 55: 1763-1775.
  8. Бобкова И. Н., Козловская Л. В., Рамеева А. С. и др. Клиническое значение определения экскреции с мочой маркеров эндотелиальной дисфункции и факторов ангиогенеза в оценке тубулоинтерстициального нефроза при хроническом гломерулонефрите. Тер. арх. 2007; 6: 10-16.
  9. Nakatsue T., Koike H., Han G. D. et al. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int. 2005; 67: 2239-2253.
  10. Huh W., Kim D. J., Kim M.-K. et al. Expression of nephrin in acquired human glomerular disease. Nephrol. Dial. Transplant. 2002; 17: 478-484.
  11. Forbes J. M., Bonnet F., Russo L. M. et al. Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. J. Hypertens. 2002; 20 (5): 985-992.
  12. Lewko B., Stepinski J. Hypergliycemia and mechanical stress: Targeting the renal podocyte. J. Cell. Physiol. 2009; 221 (2): 288-295.
  13. Jia J., Ding G., Zhu J. et al. Angiotensin II infusion induced nephrin expression changes and podocyte apoptosis. Am. Nephrol. 2008; 28 (3): 500-507.
  14. Koop K., Eikmans M., Baelde H. J. et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J. Am. Soc. Nephrol. 2003; 14: 2063-2071.
  15. Lemley K. V., Lafayette A., Safai G. et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int. 2002; 61: 1475-1485.

Copyright (c) 2011 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail:


© 2018-2021 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies